By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
French Developer Of "Peanut Allergy Patch" DBV Technologies Makes U.S. Debut 10/22/2014 6:33:12 AM
DBV Technologies Announces Proposed Global Offering 10/20/2014 6:40:38 AM
Peanut Allergy Biotech DBV Technologies Sets Terms For $98 Million U.S. IPO 10/16/2014 6:28:02 AM
DBV Technologies Announces Primary Endpoint Met In VIPES, Viaskin Peanut's Phase 2b Clinical Trial In Peanut Allergy 9/22/2014 10:55:12 AM
DBV Technologies To Attend The Goldman, Sachs & Co. European Biotech Symposium 8/26/2014 7:22:48 AM
DBV Technologies Completes Last "Food Challenge" Visit Of Last Peanut-Allergic Patient In VIPES Phase 2b Clinical Study 7/17/2014 10:15:00 AM
Consortium Of Food Allergy Research Completes Recruitment Of National Institutes of Health (NIH)-Sponsored Cofar6 Phase 2Trial With DBV Technologies's Viaskin® Peanut In Treatment Of Peanut Allergy 7/17/2014 6:12:23 AM
DBV Technologies To Present At Upcoming US Investors Conferences 6/17/2014 9:13:11 AM
Five Scientific Communications At The European Academy Of Allergy And Clinical Immunology Congress Further Support DBV Technologies's EPIT™ Disease Modifying Effect 6/11/2014 7:18:56 AM
DBV Technologies Announces Clinical Trial Agreement To Develop A Treatment For Milk-Induced Eosinophilic Esophagitis In Children 5/13/2014 11:54:21 AM